Here, we demonstrate the importance of FXR1 in antagonizing tumor cell senescence using human head and neck tumor tissues and multiple oral cancer cells including the cells expressing p53 wild-type and mutants. This evidence concerns the gene TP53 and lip and oral cavity carcinoma.